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Abstract 16 
Obesity is associated with endoplasmic reticulum (ER) stress and activation of the unfolded 17 
protein response (UPR) in adipose tissue. In this study we identify physiological triggers of 18 
ER stress and of the UPR in adipocytes in vitro. We show that two markers of adipose tissue 19 
remodelling in obesity, glucose starvation and hypoxia, cause ER stress in 3T3-F442A and 20 
3T3-L1 adipocytes. Both conditions induced molecular markers of the IRE1α and PERK 21 
branches of the UPR, such as splicing of XBP1 mRNA and CHOP, as well as transcription of 22 
the ER stress responsive gene BiP. Hypoxia also induced an increase in phosphorylation of 23 
the PERK substrate eIF2α. By contrast, physiological triggers of ER stress in many other cell 24 
types, such as the saturated fatty acid palmitic acid, cholesterol, or several inflammatory 25 
cytokines including TNF-α, IL-1β, and IL-6, do not cause ER stress in 3T3-F442A and 3T3-26 
L1 adipocytes. Our data suggest that physiological changes associated with remodelling of 27 
adipose tissue in obesity, such as hypoxia and glucose starvation, are more likely physiologic 28 
ER stressors of adipocytes than the lipid overload or hyperinsulinemia associated with 29 
obesity. 30 
Introduction 31 
Obesity is the leading risk factor for type 2 diabetes, cardiovascular disease, and 32 
hypertension.1, 2 Obesity affects the homeostasis of the whole body but mainly the liver and 33 
the adipose tissue, and is characterized by low grade inflammation, hyperlipidemia, and 34 
insulin resistance in surrounding and peripheral tissues.1, 2 Adipose tissue is exposed to 35 
several stresses in obesity, including inflammation, hypoxia, and endoplasmic reticulum (ER) 36 
stress.3 Limited angiogenesis, adipocyte hypertrophy and hyperplasia cause hypoxia in obese 37 
adipose tissue.4 Secretion of MCP-1 by dysfunctional adipocytes attracts circulating 38 
monocytes into adipose tissue,5, 6 while a change in the adipokine profile, including decreased 39 
adiponectin and increased leptin secretion,5 may contribute to the replacement of adipose 40 
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tissue resident alternatively activated (M2) macrophages with classically activated (M1) 41 
macrophages.6 While physiologic causes of inflammation and hypoxia in adipose tissue have 42 
been characterised, little is known about the physiologic triggers of ER stress in obese 43 
adipose tissue. At the molecular level, ER stress is caused by the build-up of misfolded 44 
proteins in the ER and activation of a signalling network called the unfolded protein response 45 
(UPR).7 The UPR attempts to restore ER homeostasis by inducing expression of genes 46 
encoding molecular chaperones and protein foldases, lipid biosynthetic enzymes, and proteins 47 
involved in ER-associated protein degradation. If the ER stress cannot be resolved, the UPR 48 
promotes apoptosis. ER stress also plays key roles in both inflammation and insulin 49 
resistance in obesity and type 2 diabetes.8, 9 50 
In mammalian cells, three UPR signalling cascades are initiated by the ER 51 
transmembrane proteins PERK, IRE1α, and ATF6. Phosphorylation of the translation 52 
initiation factor eIF2α by the protein kinase PERK inhibits general translation, but also 53 
stimulates translation of mRNAs harbouring several short upstream open reading frames in 54 
their 5’ untranslated regions. This mechanism of translational activation results in induction 55 
of the transcription factors ATF4 and C/EBP homologous protein (CHOP).10, 11 CHOP 56 
reactivates protein synthesis and oxidation in the ER.12 IRE1α up-regulates ER chaperone 57 
genes and genes involved in ER-associated protein degradation via endoribonuclease domain-58 
induced splicing of X-box protein 1 (XBP1) mRNA.13, 14 The transcription factor ATF6 59 
translocates to the nucleus after proteolytic release from the Golgi membrane by the Golgi 60 
proteases S1P and S2P15 and induces expression of genes encoding ER resident molecular 61 
chaperones and proteins functioning in ER-associated protein degradation.16, 17 Upon 62 
prolonged or irremediable ER stress the UPR induces apoptosis via activation of JNK18 by 63 
IRE1α and TRB3 by CHOP.19 64 
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The physiological factors leading to ER stress and activation of the UPR in obese 65 
adipocytes are not well characterized. For several other cell types, including hepatocytes, 66 
pancreatic β cells, and macrophages physiologic ER stressors have been reported. Saturated 67 
fatty acids (SFAs) or cholesterol loading induce an UPR in several cell types such as 68 
hepatocytes,20, 21 pancreatic β cells,22 macrophages,23 and preadipocytes.24 Inflammatory 69 
cytokines such as TNF-α, IL-6 and IL-1β, which are secreted by stressed adipocytes or 70 
macrophages recruited into inflamed adipose tissue,25 elicit an ER stress response in L929 71 
myoblast cells and hepatocytes.26, 27 Glucose starvation is the earliest identified physiological 72 
ER stressor,28, 29 while the hypoxic environment of tumours induces an UPR in tumour 73 
cells.30-32 74 
The purpose of this study was to identify obesity-related physiological inducers of ER 75 
stress and the UPR in adipocytes by exposing in vitro differentiated 3T3-F442A adipocytes to 76 
several physiologic ER stressors, including the SFA palmitic acid, cholesterol, inflammatory 77 
cytokines, glucose starvation, and hypoxia. We report that potent physiologic ER stressors in 78 
other cell types, such as palmitic acid, cholesterol, or the inflammatory cytokines TNF-α, IL-79 
1β, and IL-6, do not induce an ER stress response in in vitro differentiated 3T3-F442A or 80 
3T3-L1 adipocytes. Glucose starvation and hypoxia, however, induce markers of ER stress, 81 
such as splicing of XBP1 mRNA, transcriptional activation of ER stress responsive genes 82 
including BiP, and ERDJ4, CHOP and phosphorylation of eIF2α. Our results suggest that 83 
hypoxia and glucose starvation are likely physiologic ER stressors for adipocytes in vivo. 84 
Results 85 
Palmitate does not induce ER stress in adipocytes 86 
To identify which obesity-related physiological factors trigger the UPR in adipocytes we 87 
exposed in vitro differentiated 3T3-F442A and 3T3-L1 adipocytes to several compounds 88 
whose plasma levels are elevated in obesity,33-39 including palmitic acid, cholesterol, and the 89 
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inflammatory cytokines TNF-α, IL-1β, and IL-6. 3T3-F442A adipocytes were chosen 90 
because these cells form normal adipose tissue without the addition of exogenous inducers 91 
when implanted subcutaneously into athymic mice.40, 41 3T3-L1 adipocytes were included to 92 
provide a second source of adipocytes. Both cell lines were differentiated for 12 d and the 93 
percentage of cells with an increased lipid content determined by flow cytometry with the 94 
fluorescent lipid probe nile red.42 Flow cytometry revealed a mean fluorescence increase of 95 
3.2 ± 0.2 fold upon differentiation of 3T3-L1 cells (Fig. 1A). In differentiated 3T3-F442A 96 
cells two populations with 2.9 ± 0.1 fold and 25 ± 2 fold increases in nile red fluorescence 97 
were distinguishable (Fig. 1B). An ~3 fold increase in nile red fluorescence in differentiated 98 
3T3-L1 adipocytes and the larger population of differentiated 3T3-F442A adipocytes is in 99 
good agreement with previously published increases in nile red fluorescence during 100 
differentiation of human adipocytes43 and adipogenic differentiation of the murine embryonic 101 
stem cell line CGR8.44 Quantitation of the histograms for the nile red fluorescence by 102 
constructing the probability distribution for the increase in nile red fluorescence upon 103 
differentiation and the constraint that the nile red fluorescence of adipocytes has to be greater 104 
by at least two standard deviations of the mean nile red fluorescence of undifferentiated cells 105 
than the nile red fluorescence of undifferentiated cells reveals that 72 ± 3 % of the 3T3-L1 106 
and 80 ± 1 % of the 3T3-F442A cells acquired a lipid-laden phenotype. These degrees of 107 
differentiation are comparable to previously published data.45 108 
The granularity of cells increases during differentiation into adipocytes because of the 109 
accumulation of lipid droplets.46 This increase in granularity is reflected by an increase in the 110 
side scatter of the exciting laser beam47 and is also seen after differentiation of both 3T3-L1 111 
and 3T3-F442A cells for 12 d (Fig. 1C-D). The side scatter of the highly fluorescent 3T3-112 
F442A adipocyte population (≥ 300 A.U. in Fig. 1B) is significantly higher than the side 113 
scatter of the weaker fluorescent population (< 300 A. U., Fig. S2), suggesting that the highly 114 
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fluorescent cells contain more lipid droplets than the weaker fluorescing population. Forward 115 
scatter, which is affected by cell size and shape,47 decreases in 3T3-L1 cells and becomes 116 
more heterogeneous in 3T3-F442A cells (Fig. 1E-F). Taken together, these data suggest that 117 
the majority of the 3T3-L1 and 3T3-F442A cells have acquired a lipid-laden phenotype 12 d 118 
after initiation of adipogenic differentiation. 119 
To determine whether palmitic acid causes ER stress in adipocytes in vitro, 3T3-L1 and 120 
3T3-F442A adipocytes were incubated with different concentrations (0–1 mM) of palmitate 121 
complexed to fatty acid-free bovine serum albumin (BSA) for up to 48 h. The activity of the 122 
PERK branch of the UPR was assessed by Western blotting for CHOP, while activation of 123 
IRE1α was monitored by measuring splicing of XBP1 mRNA. Exposure of adipocytes to up 124 
to 1 mM palmitate for 48 h did not elevate CHOP levels (Fig. 2A-B), induce detectable levels 125 
of XBP1 splicing (Fig. 2C-D, S3-7), or elevate mRNA levels for the ER stress responsive 126 
genes BiP (Fig. 3A-B), CHOP (Fig. 3C-D), or ERDJ4 (Fig. 3E-F) especially when compared 127 
to the large increases in mRNA levels of these genes and CHOP protein levels in 128 
thapsigargin-treated adipocytes (Figs. 2A-B and 3). Treatment with palmitate complexed to 129 
BSA for 8 or 24 h did also not induce XBP1 splicing in 3T3-F442A adipocytes (Figs. S5-7). 130 
Palmitate did also not affect the viability of 3T3-F442A adipocytes over a period of up to 48 131 
h, while incubation with 1 μM thapsigargin, which causes ER stress by depleting ER luminal 132 
Ca2+ stores,48 for 48 h decreased viability by ~37% (Fig. 2E). Palmitate did also not inhibit 133 
insulin-stimulated AKT serine 473 phosphorylation in 3T3-F442A adipocytes (Fig. 4A), 134 
which is consistent with several other reports.49-56 To validate that our BSA-palmitate 135 
complexes induce ER stress, we characterised XBP1 splicing in undifferentiated 136 
preadipocytes exposed to palmitate complexed to BSA. Exposure of preadipocytes to 137 
palmitate complexed to BSA induces XBP1 splicing in these cells.24 Indeed, palmitate 138 
induced XBP1 splicing in undifferentiated preadipocytes (Figs. 2F and S8) and also inhibited 139 
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insulin action in these cells (Fig. 4B). Collectively, these results show that the SFA palmitic 140 
acid does not induce ER stress in adipocytes. 141 
Cholesterol does not induce an UPR in adipocytes 142 
To characterize whether cholesterol elicits ER stress in adipocytes we exposed differentiated 143 
3T3-F442A and 3T3-L1 adipocytes to 100 μg/ml AcLDL for 48 h. AcLDL did not elevate 144 
CHOP levels (Fig. 5A-B), induce XBP1 splicing (Figs. 5C-D and S9A-B), or elevate BiP or 145 
CHOP mRNA levels (Fig. 6). We, therefore, repeated these experiments in the presence of 146 
the ACAT inhibitor TMP-153 to inhibit cholesterol esterification and to elevate intracellular 147 
free cholesterol levels. After 24 h no changes in expression of CHOP or in XBP1 splicing 148 
were observed (data not shown). 48 h of treatment with AcLDL and TMP-153 did not 149 
increase CHOP protein levels (Fig. 5A-B), induce XBP1 splicing (Fig. 5C-D), or elevate the 150 
mRNA levels for BiP (Fig. 6A-B) or CHOP (Fig. 6C-D). To validate that AcLDL can, in 151 
principle, activate the UPR, we repeated these experiments with in vitro differentiated THP-1 152 
macrophages which are known to develop ER stress in response to cholesterol overloading.57 153 
In differentiated THP-1 macrophages AcLDL induced XBP1 splicing both in the presence 154 
and absence of TMP-153 (Figs. 5E and S9C). Treatment of THP-1 macrophages with TMP-155 
153 alone also increased XBP1 splicing ~2.6 fold (Figs. 5E and S9C). These results suggest 156 
that exposure of adipocytes to AcLDL does not cause ER stress. 157 
Proinflammatory cytokines do not induce ER stress in adipocytes 158 
To study whether inflammatory cytokines induce ER stress in adipocytes we exposed 159 
differentiated 3T3-F442A adipocytes to various concentrations of TNF-α, IL-6, or IL-1β for 160 
up to 24 h. Incubation of adipocytes with increasing concentrations of TNF-α for 24 h did not 161 
affect the viability of these cells (Fig. 7A), but also failed to induce XBP1 splicing (Figs. 7B 162 
and S10). Various concentrations of IL-6 and IL-1β also failed to induce XBP1 splicing over 163 
a period of 24 h (Figs. 7D-E and S11-12). To validate that the cytokines possess biological 164 
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activity we characterized activation of the MAPK kinase JNK in preadipocytes. All three 165 
cytokines stimulated phosphorylation of JNK (Fig. 7C and F), thus providing evidence that 166 
the cytokine preparations we utilised possess biological activity. Taken together, these data 167 
suggest that the inflammatory cytokines TNF-α, IL-6, and IL-1β do not cause ER stress in 168 
adipocytes. 169 
Glucose starvation induces ER stress in adipocytes 170 
Prolonged exposure of cells to glucose concentrations of <0.2 g/l induces the ER resident 171 
chaperones BiP and GRP94,28, 58 whose expression is controlled by XBP1 and ATF6. To 172 
characterize whether glucose starvation, which may be caused by the poor vascularization of 173 
the expanding adipose tissue in obesity, can induce ER stress in adipocytes, we maintained in 174 
vitro differentiated 3T3-F442A and 3T3-L1 adipocytes for up to 24 h in serum free medium 175 
supplemented with 2 mM L-glutamine but completely lacking glucose. Glutaminolysis serves 176 
as an energy source in this medium.59, 60 Glucose starvation for 24 h induced CHOP potently 177 
in both 3T3-F442A and 3T3-L1 adipocytes (Fig. 8A-B). XBP1 splicing peaked 12 h after 178 
induction of glucose starvation (Fig. S13A) and remained elevated for the next 36 h in 3T3-179 
F442A-adipocytes (Figs. 8C-D and S13B). 24 h of glucose starvation also induced XBP1 180 
splicing in 3T3-L1 adipocytes and elevated the steady-state mRNA levels of CHOP, BiP, and 181 
ERDJ4, and, to a lesser extent, EDEM1 and VEGFA mRNAs in 3T3-F442A adipocytes (Fig. 182 
8E). Thus, glucose starvation causes ER stress in adipocytes which coincides with increased 183 
expression of the pro-angiogenic factor VEGFA. 184 
Hypoxia causes ER stress in adipocytes 185 
We characterized whether hypoxia causes ER stress in in vitro differentiated 3T3-F442A 186 
adipocytes, because hypoxia is another physiological alteration in poorly vascularized obese 187 
adipose tissue.3 In vitro differentiated 3T3-F442A adipocytes were cultured in 0.5% O2 for up 188 
to 8 h before protein extraction and characterisation of ER stress markers and the hypoxia 189 
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marker HIF1α61 by Western blotting. Hypoxia increased HIF1α levels within 2 h (Fig. 9A-B) 190 
and also led to an increase in eIF2α phosphorylation (Fig. 9A-B), XBP1 splicing (Fig. 9C-D), 191 
and BiP mRNA levels (Fig. 9E-F). The increases in XBP1 splicing, BiP mRNA levels, and 192 
eIF2α phosphorylation, once manifested, persisted throughout the time course of the 193 
experiment. Collectively, these data show that hypoxia induces ER stress in adipocytes. 194 
Discussion 195 
We present evidence that glucose starvation and hypoxia (Figs. 8 and 9), but not palmitate 196 
(Figs. 2, 3 and S3-7), cholesterol (Figs. 5, 6, and S9), or several inflammatory cytokines (Fig. 197 
7 and S10-12) cause ER stress in two in vitro adipocyte models, 3T3-F442A and 3T3-L1. 198 
These data suggest that the poor vascularization of adipose tissue in obesity causes ER stress 199 
in adipocytes, because adipose tissue expansion in obesity leads to formation of poorly 200 
vascularized, hypoxic areas.3, 4 Glucose starvation may contribute to the adverse effects of 201 
hypoxia on adipose tissue, because obese adipocytes reach diameters that are comparable to 202 
the maximum distance of diffusive glucose supply from a blood vessel.62-64 The large overlap 203 
of the effects of hypoxia and ER stress on adipose tissue, including inflammation,4 insulin 204 
resistance,65 changes in adiponectin secretion,66 and increased angiogenesis,67-69 suggests that 205 
ER stress may contribute to or mediate the effects of hypoxia on adipocytes. 206 
Our work also suggests that palmitate, cholesterol, and inflammatory cytokines do not 207 
elicit an ER stress response in adipocytes. The mRNA expression for two ER stress sensors, 208 
IRE1α and PERK, is similar in preadipocytes and adipocytes (Fig. S14), which suggests that 209 
increased basal activity of these ER stress signalling pathways cannot explain the protection 210 
of adipocytes from palmitate- or cholesterol-induced ER stress. A dominant feature of 211 
adipocyte differentiation is the induction of nearly all enzymes of fatty acid and 212 
triacylglycerol synthesis, including stearoyl-CoA desaturases and diacylglycerol 213 
acyltransferases.70, 71 Hence, adipocytes may be protected from palmitate-induced ER stress 214 
 10 
 
 
 
because of their greatly increased ability to dispose of excess palmitate in their triacylglycerol 215 
pool.72 The expansion of the triacylglycerol pool will also increase the storage capacity of 216 
adipocytes for cholesterol73, 74 and thus may explain why cholesterol does not induce ER 217 
stress in adipocytes. Increased cholesterol efflux due to increased expression of the 218 
cholesterol transporter ABCA175, 76 may also contribute to this cholesterol resistance. 219 
Induction of several antioxidant enzymes77-79 and increased NADPH generation80 may protect 220 
adipocytes against ER stress caused by inflammatory cytokines, because these cytokines 221 
cause ER stress via production of reactive oxygen species.27, 81, 82 222 
Our conclusions differ from conclusions drawn in other studies, which suggest that TNF-223 
α,83 free fatty acids,84-87 and cholesterol88 induce ER stress in adipocytes in vitro. Koh et al.83 224 
and Jeon et al.85 have reported that TNF-α and palmitate elevate phosphorylation of eIF2α, 225 
induce ATF3 mRNA and activate JNK in 3T3-L1 adipocytes and, on the basis of these 226 
changes, concluded that TNF-α and palmitate cause ER stress in adipocytes. eIF2α 227 
phosphorylation and the increase in ATF3 mRNA downstream of eIF2α phosphorylation are 228 
controlled by four protein kinases89 of which only PERK directly responds to ER stress.90 229 
JNK is activated by many stresses.91 The absence of an increase in XBP1 splicing (Figs. 2C-230 
D, 7B, S3-7, and S10), which is a more specific marker for ER stress, suggests that other 231 
stresses are responsible for the increase in the stress markers monitored by Koh et al.83 and 232 
Jeon et al.85 Kawasaki et al.86 have reported that exposure of 3T3-L1 adipocytes to 50 μg/ml 233 
of a free fatty acid mixture derived from human serum induces XBP1 splicing, ATF4, BiP, 234 
CHOP, EDEM, ERDJ4, and PDI mRNAs. Palmitic acid is considered to be the fatty acid 235 
with the greatest potential for cell injury,92 but elicits ER stress, insulin resistance, or cell 236 
injury only at much higher concentrations in several cell types (Fig. 2F and refs. 21, 22, 24, 237 
93) and does not induce ER stress in 3T3-F442A or 3T3-L1 adipocytes (Figs. 2, 3, and S3-7). 238 
Therefore, compounds other than the SFAs present in the fatty acid mixture used by 239 
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Kawasaki et al.86 seem to be causing ER stress in adipocytes. Jiao et al.87 reported that a 240 
mixture of lauric, myristic, oleic, linoleic, and arachidonic acids induces ER stress and 241 
potently inhibits insulin-stimulated AKT serine 473 and threonine 308 phosphorylation in in 242 
vitro differentiated 3T3-L1 adipocytes. These results contradict not only our observations 243 
(Figs. 2, 3, and S3-7) but also several other papers which have reported that the unsaturated 244 
fatty acids oleic and linoleic acid protect cells from the negative effects of SFAs,94-100 that the 245 
medium-chain fatty acids lauric and myristic acid do not induce insulin resistance,52 and that 246 
palmitate does not affect insulin-stimulated AKT phosphorylation in adipocytes.49-56 Chen et 247 
al.88 reported that oxLDL induces BiP and CHOP in 3T3-L1 adipocytes and suggested that 248 
intracellular cholesterol overload may be partially responsible for this ER stress response. 249 
Both AcLDL and oxLDL are taken up via the scavenger receptor A by adipocytes.101 We 250 
have not observed activation of XBP1 splicing in 3T3-F442A or 3T3-L1 adipocytes exposed 251 
to AcLDL (Figs. 5 and S9), which suggests that an oxidized lipid or oxidized protein 252 
component of oxLDL,102 but not cholesterol, induces ER stress in adipocytes in vitro. 253 
In conclusion, our work shows that glucose and oxygen deprivation cause ER stress in 254 
adipocytes in vitro. In obesity, the rapid expansion of the adipose tissue rather than elevated 255 
SFAs, cholesterol, or proinflammatory cytokine levels, may be responsible for ER stress in 256 
adipocytes. Future work should address whether improved vascularization of obese adipose 257 
tissue, either through genetic or pharmacologic means, can mitigate ER stress in this tissue. 258 
Materials and Methods 259 
Antibodies and reagents. Antibodies against AKT (cat. no. 4691), phosphoserine 473-AKT 260 
(cat. no. 4060), CHOP (cat. no. 2895), phospho-JNK (cat. no. 4668), JNK (cat. no. 9258), and 261 
phospho-eIF2α (cat. no. 9721) were purchased from Cell Signaling Technology Inc. The anti-262 
eIF2α antibody (cat. no. sc-11386) was purchased from Santa Cruz Biotechnology Inc., the 263 
anti-HIF1α antibody (cat. no. AF1935) from R&D Systems, the anti-GAPDH antibody (cat. 264 
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no. G8795) and the monoclonal anti-β-actin antibody (cat. no. A2228) from Sigma-Aldrich. 265 
The goat anti-rabbit-IgG (H+L)-horseradish peroxidase (HRP)-conjugated secondary 266 
antibody (cat. no. 7074S) was bought from Cell Signaling Technology Inc. The  goat anti-267 
mouse IgG (H+L)-HRP-conjugated antibody (cat. no. 31432) and the mouse anti-goat IgG 268 
(H+L)-HRP-conjugated antibody (cat. no. 31400) were purchased from Thermo Fisher 269 
Scientific. Thapsigargin, dexamethasone (cat. no. D4902), 3-isobutyl-1-methylxanthine 270 
(IBMX, cat. no. I5879), insulin (cat. no. I0516), palmitic acid (cat. no. P5585), fatty acid free 271 
bovine serum albumin (BSA, cat. no. A3803), BSA (cat. no. A2153), and thiazolyl blue 272 
tetrazolium bromide (MTT, cat. no. M5655), and 9-diethylamino-5H-benzo[α]phenoxazine-273 
5-one (nile red, cat. no. N3013) were purchased from Sigma-Aldrich. TMP-153 was 274 
purchased from Enzo Life Sciences. Native human acetylated LDL (cat. no. 5685-3404) was 275 
purchased from AbD Serotec, IL-1β (cat. no. RIL1BI) from Thermo Fisher Scientific, IL-6 276 
(cat. no. PHC0066) from Life Technologies, and human TNF-α (cat. no. 8902) from Cell 277 
Signaling Technology Inc. 278 
Cell culture. 3T3-L1 murine preadipocytes103 were obtained from the ATCC and were 279 
maintained as subconfluent cultures in Dulbecco’s modified Eagle’s medium (DMEM) 280 
supplemented with 4.5 g/l D-glucose, 2 mM L-glutamine and 10% (v/v) bovine calf serum. 281 
3T3-F442A murine preadipocytes104 were maintained in DMEM supplemented with 4.5 g/l 282 
D-glucose, 2 mM L-glutamine and 10% (v/v) foetal bovine serum (FBS). For 283 
differentiation,45 both cell lines were grown to confluence. Two days post-confluency, 284 
differentiation was induced by addition of 1 μg/ml insulin, 0.5 mM IBMX, and 0.25 μM 285 
dexamethasone to the medium. The cells were maintained in this medium for three days and 286 
then for two more days in medium containing 1 μg/ml insulin. After five days of 287 
differentiation insulin was omitted from the medium and the cells were maintained for 288 
another seven days. In all experiments both 3T3-F442A and 3T3-L1 adipocytes were used 12 289 
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d after induction of differentiation. The THP-1 human monocytic leukaemia cell line105 was 290 
maintained in RPMI 1640 medium containing 10% (v/v) foetal bovine serum (FBS) and 2 291 
mM L-glutamine. The cells were differentiated into macrophages by incubation with 50 nM 292 
phorbol-12-myristate 13-acetate (PMA) for 3 d, followed by incubation for 1 d without 293 
PMA.106 Before addition of AcLDL or TMP-153 the cells were serum-starved for 7 h. 294 
Flow cytometry. Cells were stained with nile red and analysed by flow cytometry essentially 295 
as described before.42 In brief, cells were trypsinised, washed once with DMEM 296 
supplemented with 4.5 g/l D-glucose, 2 mM L-glutamine and 10% (v/v) bovine calf serum, 297 
and then with phosphate-buffered saline (PBS, 4.3 mM Na2HPO4, 1.47 mM KH2PO4, 27 mM 298 
KCl, 137 mM NaCl, pH 7.4), stained for 5 min with 100 ng/ml nile red in PBS, washed once 299 
with PBS and immediately analysed by flow cytometry on a BD FACSCalibur Flow 300 
Cytometer (BD Biosciences) at a LO flow rate. For each sample ~50,000 gated events were 301 
collected. Nile red fluorescence was excited at 488 nm and its fluorescence emission 302 
collected using the FL-1 (530/30 nm) band pass filter set. The instrument settings for 3T3-L1 303 
cells were FSC – E-1 (lin, Amp gain = 4.50), SSC – 326 V (lin, Amp gain = 1.00), and FL1 – 304 
275 V (log, Amp gain = 1.00), and for 3T3-F442A cells FSC – E-1 (lin, Amp gain = 4.50), 305 
SSC – 280 V (lin, Amp gain = 1.00), and FL1 – 275 V (log, Amp gain = 1.00). No thresholds 306 
were applied. Data were analysed in WinMDI 2.9 and graphs prepared in GraphPad Prism 307 
6.04 (GraphPad Software). Three biological replicates were analysed for each sample and 308 
results are represented as the average and standard error of these three repeats. 309 
Cell viability was determined using the MTT assay.107 In short, after TNF-α or palmitate 310 
treatment cells were incubated for 4 h at 37°C with 0.5 g/l MTT in phenol-red free DMEM 311 
containing 4.5 g/l D-glucose, and 2 mM L-glutamine or 2% (w/v) BSA, respectively. 312 
Insoluble formazan crystals were dissolved for 15 min in isopropanol containing 4 mM HCl 313 
and 0.1% (v/v) Nonidet P-40. The absorbance of the formazan solution was read at a 314 
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wavelength of 590 nm and a reference wavelength of 620 nm and the formazan absorbance 315 
expressed as the ratio of the absorbance at 590 nm to the absorbance at 620 nm. 316 
Palmitate treatment. In vitro differentiated 3T3-F442A adipocytes were serum-starved 317 
overnight in DMEM containing 4.5 g/l D-glucose, and 2 mM L-glutamine and then incubated 318 
in serum-free medium containing 2% (w/v) fatty acid-free BSA and 0.05-1 mM palmitic acid. 319 
These palmitate concentrations are in the physiological range reported for rodents and 320 
humans.108 Palmitic acid was complexed to fatty acid-free BSA as follows. In brief, palmitic 321 
acid was dissolved in ethanol and diluted 1:100 in DMEM containing 4.5 g/l D-glucose and 322 
2% (w/v) fatty acid-free BSA before addition to the cells. Control cells received ethanol 323 
diluted 1:100 into DMEM containing 4.5 g/l D-glucose and 2% (w/v) fatty acid-free BSA.109 324 
Cholesterol and cytokine treatments. In vitro differentiated adipocytes were incubated in 325 
DMEM containing 4.5 g/l D-glucose, 2 mM L-glutamine, and 100 µg/ml human acetylated 326 
LDL (AcLDL) in the presence or absence of the acyl-CoA:cholesterol acyltransferase 327 
(ACAT) inhibitor TMP-153 at a final concentration of 0.6 μM. The cells were incubated with 328 
cytokines in serum-free medium. 329 
D-Glucose starvation experiments were performed by incubating the cells for the indicated 330 
times in D-glucose-free DMEM supplemented with 2 mM L-glutamine. Control cells ‘+ D-331 
glucose’) were incubated for the same time in DMEM containing 4.5 g/l D-glucose and 2 332 
mM L-glutamine. 333 
Hypoxia experiments were performed using a Billups-Rotenberg hypoxia chamber. A pre-334 
analysed gas mixture of 0.5% (v/v) O2, 5% (v/v) CO2 and nitrogen (BOC Industrial Gases) 335 
was flushed through the chamber at a flow rate of 25 l/min for 5 min to completely replace air 336 
inside the chamber with the gas mixture. The hypoxia chamber was incubated at 37°C for the 337 
indicated times. Cells were rapidly harvested and lysed at 4ºC using degassed buffers as 338 
described before.110 339 
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RNA analysis. RNA was extracted and analysed by reverse transcriptase (RT) PCR as 340 
described before.110 Primers for quantitative PCR (qPCR) are listed in Table 1. RT-qPCR 341 
data were standardized to ACTB as loading control. The percentage of XBP1 splicing was 342 
calculated by dividing the signal for spliced XBP1 mRNA by the sums of the signals for 343 
spliced and unspliced XBP1 mRNAs. Band intensities were quantitated using ImageJ.  344 
Protein extraction and Western blotting. Cells were washed three times with ice-cold PBS 345 
and lysed in RIPA buffer [50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.5% (w/v) sodium 346 
deoxycholate, 0.1% (v/v) Triton X-100, 0.1% (w/v) SDS] containing Roche complete 347 
protease inhibitors (cat. no. 11836153001, Roche Applied Science) and phosphatase 348 
inhibitors  (cat. no. 04 906 837 001, Roche Applied Science) as described before.110 349 
Proteins were separated by SDS-PAGE on 4-20% Criterion TGX Precast gels (cat. no. 350 
567-1094, Bio-Rad Laboratories) and transferred to polyvinylidene difluoride (PVDF) 351 
membranes (Amersham HyBondTM-P, pore size 0.45 μm, cat. no. RPN303F, GE Healthcare) 352 
by semi-dry electrotransfer in 0.1 M Tris, 0.192 M glycine, and 5% (v/v) methanol at 2 353 
mA/cm2 for 60-75 min. Membranes were then blocked for 1 h in 5% (w/v) skimmed milk 354 
powder in TBST [20 mM Tris-HCl, pH 7.6, 137 mM NaCl, and 0.1% (v/v) Tween-20] for 355 
antibodies against non-phosphorylated proteins and 5% BSA in TBST for antibodies against 356 
phosphorylated proteins. Incubations with antibodies were performed over night at 4°C with 357 
gentle agitation. Blots were washed three times with TBST and then probed with secondary 358 
antibody for 1 hour at room temperature. The rabbit anti-AKT, anti-phospho-S473-AKT, 359 
anti-phospho-S51-eIF2α, anti-JNK and anti-phospho-JNK antibodies were used at a 1:1,000 360 
dilution in TBST + 5% (w/v) BSA. The rabbit anti-eIF2α antibody was used at a 1:500 361 
dilution in TBST + 5% (w/v) skimmed milk powder. Membranes were developed with goat 362 
anti-rabbit-IgG (H+L)-horseradish peroxidase (HRP)-conjugated secondary antibody at a 363 
1:1,000 dilution in TBST + 5% (w/v) skimmed milk powder for 1 h at room temperature. The 364 
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mouse anti-CHOP antibody and anti-β-actin antibodies were used at a 1:1,000 dilution in 365 
TBST + 5% (w/v) skimmed milk powder, and the mouse anti-GAPDH antibody at a 1:30,000 366 
dilution in TBST + 5% (w/v) skimmed milk powder. These antibodies were developed with 367 
goat anti-mouse IgG (H+L)-horseradish peroxidase (HRP)-conjugated secondary antibody at 368 
a 1:20,000 dilution in TBST 5% (w/v) skimmed milk powder for 1 h at room temperature. 369 
The goat anti-HIF1α antibody was used at a dilution of 1:500 in TBST + 5% (w/v) skimmed 370 
milk powder and developed with mouse anti-goat IgG (H+L)-HRP-conjugated antibody at a 371 
dilution of 1:30,000 in TBST + 5% (w/v) skimmed milk powder for 1 h at room temperature. 372 
To reprobe blots for detection of nonphosphorylated proteins, membranes were stripped using 373 
Restore Western Blot Stripping Buffer (Thermo Fisher Scientific, Loughborough, UK, cat. 374 
no. 21059) and blocked with 5% (w/v) skimmed milk powder in TBST. 375 
For signal detection, Pierce ECL Western Blotting Substrate (cat. no. 32209) or Pierce 376 
ECL Plus Western Blotting Substrate (cat. no. 32132) from Thermo Fisher Scientific were 377 
used. Blots were exposed to CL-X PosureTM film (cat. no. 34091, Thermo Fisher Scientific). 378 
Exposure times were adjusted on the basis of previous exposures to obtain exposures in the 379 
linear range of the film. Films were scanned on a CanoScan LiDE 600F scanner (Canon) and 380 
saved as tif files. Bands were quantified using ImageJ exactly as described under the heading 381 
“Gels Submenu” on the ImageJ web site 382 
(http://rsb.info.nih.gov/ij/docs/menus/analyze.html#plot). Peak intensities for the 383 
experimental antibody were then divided by the peak intensities obtained with the antibody 384 
for the loading control in the corresponding lane to correct for differences in loading between 385 
individual lanes. All loading control-corrected peak intensities obtained for one Western blot 386 
were then expressed relative to the loading control-corrected peak intensity of the 0 h sample. 387 
Statistical analysis. All data are presented as the average and standard error of three 388 
independently differentiated adipocyte cultures. Errors were propagated using the law of error 389 
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propagation for random, independent errors.111 Statistical analyses were performed in 390 
GraphPad Prism 6.04. The statistical tests and corrections for multiple comparison used to 391 
analyse the data are described in detail in the figure legends. 392 
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Figure legends 715 
Figure 1. Adipocyte differentiation of 3T3-L1 and 3T3-F442A cells. (A, B) Nile red 716 
fluorescence, (C, D) side scatter (SSC-H), and (E, F) forward scatter (FSC-H) of (A, C, E) 717 
3T3-L1 and (B, D, F) 3T3-F442A cells before (0 d, grey lines) and 12 d after induction of 718 
adipocyte differentiation (black lines). The light grey lines represent the autofluorescence of 719 
cells differentiated for 12 d. Dot plots of the side scatter SSC-H versus the forward scatter 720 
SSC-H for 3T3-L1 and 3T3-F442A cells before and 12 d after differentiation are shown in 721 
Fig. S1. The mean nile red fluorescence of preadipocytes is significantly different from the 722 
mean nile red fluorescence of differentiated adipocytes in a one way analysis of variance 723 
(ANOVA) test with Dunnett’s correction for multiple comparisons112, 113 (p < 0.0001 for both 724 
3T3-L1 and 3T3-F442A cells). 725 
Figure 2. Palmitate does not induce CHOP protein expression or XBP1 splicing in 726 
adipocytes. (A, B) CHOP expression in in vitro differentiated (A) 3T3-F442A adipocytes 727 
and (B) 3T3-L1 adipocytes exposed to the indicated concentrations of palmitate complexed to 728 
BSA for 48 h. Relative (rel.) CHOP signals were corrected for the loading controls GAPDH 729 
or β-actin. The bar graphs show the average and standard error of three independent repeats. 730 
Differences are not statistically significant (p = 0.42 for 3T3-F442A adipocytes and p = 0.10 731 
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for 3T3-L1 adipocytes in a repeated measures ANOVA test that compares the treated samples 732 
to the untreated sample. Equal variabilities of the differences were assumed for the treated 733 
and untreated samples and Dunnett’s correction for multiple comparisons112, 113 was used). 1 734 
μM thapsigargin (Tg) was used as a positive control for induction of ER stress. Thapsigargin-735 
treated samples were compared to untreated samples using a two-tailed, unpaired t-test. (C, 736 
D) XBP1 splicing in in vitro differentiated (C) 3T3-F442A adipocytes and (D) 3T3-L1 737 
adipocytes incubated for 48 h with the indicated concentrations of BSA-complexed palmitate. 738 
% splicing indicates the percentage of spliced XBP1 mRNA, for which the average and 739 
standard error of three independent experiments are shown. Abbreviations: u – unspliced 740 
XBP1 mRNA, s – spliced XBP1 mRNA. (E) MTT assay on in vitro differentiated 3T3-F442A 741 
adipocytes incubated for 48 h with the indicated concentrations of BSA-complexed palmitate. 742 
A repeated measures ANOVA test was used to compare the treated samples to the untreated 743 
sample. Equal variabilities of the differences were assumed for the treated and untreated 744 
samples and Dunnett’s correction for multiple comparisons112, 113 was applied. (F) XBP1 745 
splicing in 3T3-F442A preadipocytes incubated for 12 h with the indicated concentrations of 746 
BSA-complexed palmitate. Abbreviations: * - p < 0.05, ** - p < 0.0, *** - p < 0.001, and 747 
**** - p < 0.0001. 748 
Figure 3. Palmitate does not induce BiP, CHOP, or ERDJ4 transcription in adipocytes. 749 
(A, B) BiP mRNA, (C, D) CHOP mRNA, and (E, F) ERDJ4 mRNA levels in in vitro 750 
differentiated (A, C, E) 3T3-F442A and (B, D, F) 3T3-L1 adipocytes incubated for 48 h with 751 
the indicated concentrations of BSA-complexed palmitate. The differences in BiP mRNA (p 752 
= 0.10 for 3T3-F442A adipocytes and p = 0.34 for 3T3-L1 adipocytes), CHOP mRNA (p = 753 
0.11 for 3T3-F442A adipocytes and p = 0.41 for 3T3-L1 adipocytes), and ERDJ4 mRNA (p 754 
= 0.48 for 3T3-F442A adipocytes and p = 0.41 for 3T3-L1 adipocytes) levels in the untreated 755 
and palmitate treated samples are not statistically significant. A repeated measures ANOVA 756 
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test with Dunnett’s correction for multiple comparisons112, 113 and assuming equal 757 
variabilities of the differences was used to compare the palmitate-treated samples to the 758 
untreated sample. Thapsigargin-treated samples were compared to untreated samples using a 759 
two-tailed, unpaired t-test. 760 
Figure 4. Palmitate does not inhibit insulin signalling in 3T3-F442A adipocytes. (A) 761 
Serum-starved 3T3-F442A adipocytes and (B) serum-starved undifferentiated 3T3-F442A 762 
cells were treated with the indicated concentrations of BSA-complexed palmitic acid for 48 h 763 
before stimulation with 100 nM insulin for 15 min. Phosphorylation of AKT at serine 473 764 
and total AKT levels were determined by Western blotting. 765 
Figure 5. Cholesterol loading does not induce CHOP protein expression or XBP1 766 
splicing in adipocytes. (A, B) CHOP protein levels and (C, D) XBP1 splicing in in vitro 767 
differentiated (A, C) 3T3-F442A and (B, D) 3T3-L1 adipocytes incubated for 48 h with 768 
human acetylated LDL (AcLDL), AcLDL and 0.6 μM of the ACAT inhibitor TMP-153, 0.6 769 
μM TMP-153, 1.0 μM Tg, or left untreated (‘-‘). The average and standard error of three 770 
independent experiments are shown in the bar graphs. Differences in CHOP protein levels 771 
between the untreated sample and the samples treated with AcLDL, AcLDL and 0.6 μM 772 
TMP-153, and 0.6 μM TMP-153 are not statistically significant (p = 0.26 for 3T3-F442A 773 
adipocytes and p = 0.35 for 3T3-L1 adipocytes in a repeated measures ANOVA test with 774 
Dunnett’s correction for multiple comparisons112, 113 comparing the treated samples to the 775 
untreated samples and assuming equal variabilities of the differences). (E) XBP1 splicing in 776 
untreated in vitro differentiated human THP-1 macrophages and macrophages incubated for 777 
16 h with AcLDL, AcLDL + 0.6 μM TMP-153, 0.6 μM TMP-153, or 1.0 μM Tg. 778 
Figure 6. Cholesterol loading does not induce BiP or CHOP transcription in adipocytes. 779 
(A, B) BiP mRNA and (C, D) CHOP mRNA levels in in vitro differentiated (A, C) 3T3-780 
F442A and (B, D) 3T3-L1 adipocytes incubated for 48 h with human acetylated LDL 781 
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(AcLDL), AcLDL and 0.6 μM of the ACAT inhibitor TMP-153, 0.6 μM TMP-153, 1.0 μM 782 
Tg, or left untreated (‘-‘). The average and standard error of three independent experiments 783 
are shown. Differences are not statistically significant (BiP mRNA: p = 0.34 for 3T3-F442A 784 
adipocytes and p = 0.11 for 3T3-L1 adipocytes; CHOP mRNA: p = 0.09 for 3T3-F442A 785 
adipocytes and p = 0.11 for 3T3-L1 adipocytes). p values were obtained from a repeated 786 
measures ANOVA test comparing the samples treated with AcLDL, AcLDL and 0.6 μM 787 
TMP-153, and 0.6 μM TMP-153 to the untreated samples and assuming equal variabilities of 788 
the differences. Dunnett’s correction for multiple comparisons112, 113 was applied. 789 
Thapsigargin-treated samples were compared to untreated samples using a two-tailed, 790 
unpaired t-test. 791 
Figure 7. The proinflammatory cytokines TNF-α, IL-6, and IL-1β do not induce ER 792 
stress in adipocytes. (A) MTT assay on in vitro differentiated 3T3-F442A adipocytes 793 
incubated for 24 h with the indicated concentrations of TNF-α. A repeated measures ANOVA 794 
test was used to compare the treated samples to the untreated sample. Equal variabilities of 795 
the differences were assumed for the treated and untreated samples and Dunnett’s correction 796 
for multiple comparisons112, 113 was applied. (B) XBP1 splicing in in vitro differentiated 3T3-797 
F442A adipocytes incubated for 24 h with the indicated concentrations of TNF-α or 1.0 μM 798 
Tg. The average and standard error from three independent experiments are shown. (C) JNK 799 
phosphorylation in 3T3-F442A preadipocytes incubated for 30 min with 25 ng/ml TNF-α. (D 800 
and E) XBP1 splicing in in vitro differentiated 3T3-F442A adipocytes incubated for 24 h with 801 
the indicated concentrations of (D) IL-6 and (E) IL-1β. The average and standard error of two 802 
independent experiments are shown. (F) JNK phosphorylation in 3T3-F442A preadipocytes 803 
incubated for the indicated times with 200 ng/ml IL-6 or 200 ng/ml IL-1β. 804 
Figure 8. Glucose starvation induces ER stress in adipocytes. (A) CHOP protein levels in 805 
in vitro differentiated 3T3-F442A and 3T3-L1 adipocytes maintained for 24 h in the presence 806 
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of 4.5 g/l D-glucose (‘+ Glucose’) or without any glucose (‘- Glucose’). β-Actin was used as 807 
a loading control. (B) Quantitation of the Western blots shown in panel (A). (C) XBP1 808 
splicing in in vitro differentiated 3T3-F442A and 3T3-L1 adipocytes maintained for 24 h in 809 
the presence of 4.5 g/l D-glucose or without any glucose. Below the images of the agarose 810 
gels the intensity of the ethidium bromide fluorescence was plotted versus the migration 811 
distance of the PCR products. (D) Quantitation of XBP1 splicing shown in panel (C). For 812 
both cell lines the average and standard error of three independent repeats are shown. (E) 813 
Steady-state mRNA levels of CHOP, BiP, ERDJ4, EDEM1, and VEGFA mRNAs in 3T3-814 
F442A adipocytes maintained for 24 h in the presence of 4.5 g/l D-glucose or without any 815 
glucose. p values were obtained from two-tailed, unpaired t-tests. 816 
Figure 9. Hypoxia induces ER stress in adipocytes. (A-B) Induction of HIF1α and 817 
increased phosphorylation of eIF2α at serine 51 in in vitro differentiated (A) 3T3-F442A and 818 
(B) 3T3-L1 adipocytes incubated for the indicated times under 0.5% (v/v) O2. (C-D) XBP1 819 
splicing in in vitro differentiated (C) 3T3-F442A and (D) 3T3-L1 adipocytes incubated for 820 
the indicated times under 0.5% (v/v) O2. Representative gels from three biological repeats are 821 
shown. (E, F) Steady-state BiP mRNA levels in in vitro differentiated 3T3-F442A (E) and 822 
3T3-L1 (F) adipocytes incubated for the indicated times under 0.5% (v/v) O2 were 823 
determined by RT-qPCR. p values were obtained from a repeated measures ANOVA test 824 
comparing the treated samples to the untreated samples and assuming equal variabilities of 825 
the differences. Dunnett’s correction for multiple comparisons112, 113 was employed. 826 
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Table 1. Oligodeoxynucleotides. The HUGO Gene Nomenclature Committee gene names 828 
are given in brackets where these deviate from the commonly used gene names. 829 
Name Purpose Sequence 
H7961 XBP1 PCR, forward primer GATCCTGACGAGGTTCCAGA 
H7962 XBP1 PCR, reverse primer ACAGGGTCCAACTTGTCCAG 
H7994 ACTB PCR and RT-qPCR, forward primer AGCCATGTACGTAGCCATCC 
H7995 ACTB PCR and RT-qPCR, reverse primer CTCTCAGCTGTGGTGGTGAA 
H8553 BiP (HSPA5) RT-qPCR, forward primer TTCGTGTCTCCTCCTGAC 
H8554 BiP (HSPA5) RT-qPCR, reverse primer ACAGTGAACTTCATCATGCC 
H8660 VEGFA RT-qPCR, forward primer AGAGCAACATCACCATGCAG 
H8661 VEGFA RT-qPCR, reverse primer TTTGACCCTTTCCCTTTCCT 
H8736 ERDJ4 (DNAJB9) RT-qPCR, forward 
primer 
CTGTGGCCCTGACTTGGGTT 
H8737 ERDJ4 (DNAJB9) RT-qPCR, reverse 
primer 
AGGGGCAAACAGCCAAAAGC 
H8778 CHOP RT-qPCR, forward primer TCTTGAGCCTAACACGTCGAT 
H8779 CHOP RT-qPCR, reverse primer CGTGGACCAGGTTCTGCTTT 
H8796 EDEM1 RT-qPCR, forward primer TGGAAAGCTTCTTTCTCAGC 
H8797 EDEM1 RT-qPCR, reverse primer ATTCCCGAAGACGTTTGTCC 
H9106 PERK RT-qPCR, forward primer CTCAAGTTTCCTCTACTGTTCACTC
H9107 PERK RT-qPCR, reverse primer GCTGTCTCAGAACCGTTTTCCC 
H9110 IRE1α RT-qPCR, forward primer GCGCAAATTCAGAACCTACAAAGG 
H9111 IRE1α RT-qPCR, reverse primer GGAAGCGGGAAGTGAAGTAGC 
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